Inflammation, not symptoms, found to disrupt sleep in IBD patients
UC gastroenterologist offers insight on study
Impaired sleep architecture in inflammatory bowel disease (IBD) is primarily driven by inflammatory activity rather than symptomatic flares as previously thought, according to a study published in Clinical Gastroenterology and Hepatology.
Sleep architecture is the structural organization of a normal sleep cycle, encompassing the progression and distribution of different stages of sleep — light sleep, deep sleep and rapid eye movement (REM) sleep — throughout a typical night’s rest.
Susan Kais, MD, a board-certified gastroenterologist and assistant professor of clinical medicine in the Division of Digestive Diseases at the University of Cincinnati College of Medicine, noted in a recent MedCentral article that the study's results are significant, in part because of the methodology used.
Researchers used data from wearable devices and fitness trackers to track patients' long-term sleep patterns.
“In addition, the study was then able to overlap these assessments with both symptomatic and inflammatory data more readily,” she added. Kais was not involved in the study.
The study's authors said their findings suggest that significant changes in sleep, including reduced rapid eye movement (REM) and increased light sleep, occur only when inflammation is present. They said significant changes were noticed before and after patients experienced IBD flares.
Kais recommended that clinicians prioritize controlling inflammation to improve sleep disturbances in patients with IBD.
“As clinicians, we may be overlooking sleep disturbances as an important IBD metric that should be assessed more routinely. More frequent monitoring of inflammatory markers, such as C-reactive protein and fecal calprotectin, alongside the integration of wearable sleep technology devices, can detect disturbances early and guide timely, sleep-related interventions,” she said.
Kais said further studies can explore the impact of sleep interventions versus over-the-counter options.
Featured image at top: iStock/FG Trade.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.